Inception | $50,000,000 | (Nov 7, 2025)
SiteLabs | $2,000,000 | (Nov 7, 2025)
DealMaker | $20,000,000 | (Nov 7, 2025)
Certified by Founder
Lodge
XyloCor Therapeutics, Inc.
start up
United States
- King of Prussia, Pennsylvania
- 09/01/2025
- Series B
- $67,500,000
XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.
- Industry Research Services
- Website https://www.xylocor.com/
- LinkedIn https://www.linkedin.com/company/xylocor-therapeutics-inc./
Flint(US) | $15,000,000 | (Nov 7, 2025)
Subtle Computing | $6,000,000 | (Nov 7, 2025)
IndustrialMind.ai | $1,200,000 | (Nov 7, 2025)
Fintary | $10,000,000 | (Nov 7, 2025)
Graymatter Labs | $1,300,000 | (Nov 7, 2025)
Avallon AI (YC X25) | $4,600,000 | (Nov 7, 2025)
Kaizen Labs | $12,000,000 | (Nov 7, 2025)
Giga | $61,000,000 | (Nov 7, 2025)
Reevo | $80,000,000 | (Nov 7, 2025)